Industry Symposia

Novartis Lunchtime Symposium - Treating the Spectrum of NET: A Multidisciplinary Expert Forum

Date: Friday, November 9th

Time: 12:30pm – 1:45pm (Lunch boxes served for delegates) 

Title: Treating the Spectrum of NET: A Multidisciplinary Expert Forum

Chair: Prof Rod Hicks

Educational Objectives:

  • Review challenging patient cases and work with leading experts to explore diagnostic and clinical decisions to provide quality patient care
  • Review international guidelines for the management of patients with advanced NET and provide expert guidance for integration into treatment protocols
  • Discuss the importance of optimal treatment selection in a multidisciplinary setting to improve patient quality of life


Prof Rod Hicks, MD (Chair)
Director, Centre for Cancer Imaging; head, Molecular Imaging and Targeted Therapeutic Laboratory
The Sir Peter MacCallum Department of Oncology 
Co-chair, Neuroendocrine Service
Victoria, Australia

Michael Michael, MBBS (Hons), BSc(Hons), MD, FRACP MBBS (Hons), BSc(Hons), MD, FRACP
Chair of Upper Gastrointestinal Cancer Service
Peter MacCallum Cancer Centre
Victoria, Australia

Dr James Yao, MD, PhD
Professor and Chairman of GI medical oncology MD Anderson Cancer Center Houston 
Texas, United States

Simona Glasberg, MD
Head, Neuroendocrine Tumor Unit, Endocrinology and Metabolism Department
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Halfdan Sorbye, MD
Head of NET and GI Section at Department of Oncology
Haukeland University Hospital
Department of Oncology and Medical Physics
Bergen, Norway

Registration is complimentary for all APNETS attendees and lunch is included.

This session is organised and sponsored by  novartis12

Ipsen Breakfast Symposium

Date: Sunday, November 11th

Time: 7.00am to 8.30am (breakfast served from 6:45am)

Title: N.E.T - Connecting the last 110 years

Presenters: coming shortly

Chair: coming shortly

It is with great pleasure that we invite you all to this year’s Ipsen sponsored symposium – “N.E.T – Connecting the Last 110 Years” – from when Siegfried Orberndorfer first coined the term ‘karzinoide’ for what we now refer to as neuroendocrine tumours (NETs). This screening will take you back in time to 1907, on a journey through the last 110 years of NETs history, focusing on scientific discoveries, diagnostic advances and treatment developments, all of which have contributed to optimising patient care. At pivotal points of the film, our expert faculty will offer insight and opinion on the innovations and collaborations that have led to improvements in patient care over the past century.

Join us and take your seats to enjoy learning about how the past can help to shape the future.


This Breakfast Session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by Logo ipsen Pantone





Our Sponsors